581
Participants
Start Date
December 5, 2018
Primary Completion Date
December 4, 2023
Study Completion Date
March 5, 2024
INTERCEPT
Pathogen reduced RBCs
Control
Conventional RBCs
University of Pittsburgh Medical Center, Pittsburgh
Temple, Philadelphia
University of Virginia Health System, Charlottesville
Duke University Health System, Durham
Emory, Atlanta
University of Florida, Gainesville
University of Kentucky, Lexington
University of Michigan, Ann Arbor
Henry Ford Health System, Detroit
Mayo-Rochester, Rochester
University of Texas Southwestern, Dallas
Houston Methodist, Houston
University of Colorado Hospital, Aurora
University of California Los Angeles, Los Angeles
Stanford, Stanford
Bridgeport Hospital, Bridgeport
Yale New Haven Hospital, New Haven
Rhode Island Hospital, Providence
Lead Sponsor
Cerus Corporation
INDUSTRY